Annals of internal medicine
-
Dyslipidemia may occur in younger adults (defined as persons aged 21 to 39 years) and is an important risk factor for cardiovascular disease. Screening might identify younger adults with asymptomatic dyslipidemia who may benefit from lipid-lowering therapies. ⋯ Agency for Healthcare Research and Quality.
-
Biosimilars are of growing clinical, regulatory, and commercial importance. ⋯ Johns Hopkins Center of Excellence in Regulatory Science and Innovation. (PROSPERO: CRD42015025262).